Reductive amination of the tetraene macrolide antibiotic lucensomycin by para-substituted benzaldehydes and cyanoborohydride formed its N-benzyl derivatives. The physicochemical, medical, and biological properties of the obtained pimaricin derivatives were studied. Biological tests showed that the N-benzyl lucensomycin derivatives possessed high antifungal and antiviral activity. Pharmacological tests showed that the acute toxicity (LD50) of the synthesized lucensomycin derivatives was six times less than that of the starting antibiotic.
Similar content being viewed by others
References
F. Arcamone, C. Bertazzoli, A. Di Marco, et al., G. Microbiol., No. 4, 119 – 128 (1957).
F. Arcamone and M. Perego, Ann. Chim., No. 49, 345 – 351 (1959).
D. G. Manwaring, R. W. Rikards, G. Gaudiano, and V. Nicolla, J. Antibiot., 22(11), 545 – 550 (1969).
G. Gaudiano, P. Bravo, and G. Mauri, Chim. Ind. (Milano), 48(12), 1327 – 1328 (1966).
G. Gaudiano, P. Bravo, and A. Quilico, Tetrahedron Lett., No. 30, 3559 – 3565 (1966).
G. Gaudiano, P. Bravo, A. Quilico, et al., Tetrahedron Lett., No. 30, 3567 – 3571 (1966).
C. N. Chong and R. W. Rickards, Tetrahedron Lett., No. 49, 5053 – 5056 (1972).
K. Dornberger, D. Voigt, W. Ihn, et al., Tetrahedron, 32(24), 3069 – 3073 (1976).
K. Dornberger, H. Thrum, and G. Engelhardt, Tetrahedron Lett., No. 49, 4469 – 4472 (1976).
R. C. Pandey and K. L. Renehart, J. Antibiot., 29(10), 1035 – 1042 (1976).
A. Boicelli, G. Rappi, A. Ricci, et al., Tetrahedron Lett., No. 14, 1213 – 1214 (1978).
O. E. Graessle, H. F. Phares, and H. J. Robinson, Antibiot. Chemother., 12(10), 608 – 617 (1962).
Y. Kawabe, G. Takimoto, T. Ikeda, et al., Chemotherapy, 14(43), 309 – 312 (1966).
Yu. D. Shenin, V. V. Belakhov, and R. A. Araviiskii, Khim.-farm. Zh., 27, No. 2, 14 – 21 (1993); Pharm. Chem. J., 27(2), 84 – 92 (1993).
A. Yu. Sergeev and Yu. V. Sergeev, Fungal Infections [in Russian], BINOM, Moscow (2008), pp. 142 – 145.
A. Yu. Sergeev and Yu. V. Sergeev, Candidosis. Nature of the Infection, Mechanisms of Aggression and Protection, Laboratory Diagnosis, Clinic and Treatment [in Russian], Triada-X, Moscow (2001), pp. 187 – 188.
S. N. Kozlov and L. S. Strachunskii, Modern Antimicrobial Chemotherapy [in Russian], OOO Meditsinskoe Informatsionnoe Agentstvo, Moscow (2009), pp. 19 – 23.
V. Fanos and L. Cataldi, J. Chemother., 12(6), 463 – 470 (2000).
G. Deary, J. Antimicrob. Chemother., 49, Suppl. S1, 37 – 41 (2002).
J. F. Bernardo, R. Sabra, and R. A. Branch, in: Clinical Nephrotoxins, M. E. De Broe (ed.), Kluwer Academic Publishers, Dordrecht, Netherlands (2003), pp. 199 – 222.
A. H. Thomas, Analyst, 101(1202), 321 – 340 (1976).
M. T. Lamy-Freund, V. F. Ferreira, and S. Schreier, J. Antibiot., 38(6), 753 – 757 (1985).
V. V. Belakhov, Yu. D. Shenin, E. E. Nifant’ev, et al., Antibiot. Khimoter., 42(12), 6 – 9 (1997).
V. V. Belakhov, Yu. D. Shenin, and B. I. Ionin, Khim. Promst., 90(3), 128 – 132 (2013).
C. H. Kaufman and P. L. Carver, Drugs, 53(4), 539 – 549 (1997).
H. V. Bossche, F. Dromer, I. Improvisi, et al., Med. Mycol., 36(1), 119 – 128 (1998).
D. A. Stevens and K. Holmberg, Curr. Opin. Anti-Infect. Invest. Drugs, 1(3), 306 – 317 (1999).
Yu. D. Shenin and V. V. Belakhov, Chemistry of Polyene Macrolide Antibiotics, Review Information, Series “Drugs, Economics, Technology and Production Potential” [in Russian], No. 6, VNIISENTI, Moscow (1989).
Yu. D. Shenin and V. V. Belakhov, Antibiot. Khimioter., 42(4), 34 – 46 (1997).
S. B. Zotchev, Curr. Med. Chem., 10(3), 211 – 223 (2003).
S. E. Solov’eva, E. N. Olsuf’eva, and M. N. Preobrazhenskaya, Usp. Khim., 80(2), 115 – 138 (2011).
E. Capuozzo, C. Crifo, C. Salerno, and R. Strom, Drugs Exp. Clin. Res., 12(6 – 7), 19 – 26 (1986).
C. Salerno, E. Capuozzo, C. Cucco, and C. Crifo, Biochimie, 71(1), 63 – 66 (1989).
C. Salerno, E. Capuozzo, and C. Crifo, J. Liposome Res., 3(3), 671 – 678 (1993).
V. V. Belakhov, V. A. Kolodyaznaya, and B. I. Ionin, Russ. J. Appl. Chem., 85(9), 1454 – 1465 (2012).
E. E. Nifant’ev, Chemistry of Hydrophosphoryl Compounds [in Russian], Nauka, Moscow (1983), pp. 78 – 87.
R. A. Cherkasov and V. I. Galkin, Usp. Khim., 67(10), 940 – 968 (1998).
P. Sykes, A Guidebook to Mechanism in Organic Chemistry, Wiley, New York (1986) [Russian translation, Khimiya, Moscow (1991), pp. 244 – 245].
L. G. Wade, Organic Chemistry, Prentice Hall, Upper Saddle River, New Jersey, USA (1999), pp. 886 – 888.
A. P. Davis, in: Comprehensive Organic Synthesis: Selectivity, Strategy and Efficiency in Modern Organic Chemistry, B. M. Trost and I. Fleming (eds.), Pergamon Press, Oxford (1991), Vol. 8, Chap. 1.12, pp. 283 – 305.
G. W. Gribble, Chem. Soc. Rev., 27(6), 395 – 404 (1998).
B. I. Ionin, B. A. Ershov, and A. M. Kol’tsov, NMR Spectroscopy in Organic Chemistry [in Russian], Khimiya, Leningrad (1983), pp. 166 – 174.
L. A. Vetlugina and E. T. Nikitina, Antifungal Polyene Antibiotics [in Russian], Nauka, Alma-Ata (1980), pp. 15 – 16.
F.-M. Arcamone, Chem. Eur. J., 15(32), 7774 – 7791 (2009).
W. L. F. Armarego and C. L. L. Chai, Purification of Laboratory Chemicals, Butterworth-Heinemann Press, Oxford (2012).
I. P. Ashmarin and A. A. Vorob’ev, Statistical Methods in Microbiological Research [in Russian], Medgiz, Leningrad (1962), 180 pp.
M. L. Belen’kii, Elements of Quantitative Assessment of the Pharmacological Effect [in Russian], Medgiz, Leningrad (1963), 146 pp.
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Strasbourg, Mar. 18, 1986.
National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A, Wayne, PA, USA, 1997.
A. Espinel-Ingroff, K. Boyle, and D. J. Sheehan, Mycopathologia, 150(3), 101 – 115 (2001).
J. H. Rex, M. A. Pfaller, J. N. Galgiani, et al., Clin. Infect. Dis., 24(2), 235 – 247 (1997).
V. F. Uchaikin and O. V. Shamsheva, Handbook of Clinical Vaccinology [in Russian], GEOTAR-Media, Moscow (2006), 592 pp.
F. I. Ershov and M. G. Romantsov, Drugs Used for Viral Diseases [in Russian], GEOTAR-Media, Moscow (2007), pp. 278 – 281.
A. Vertut-Croquin, J. Brajtburg, and G. Medoff, Cancer Res., 46(12), 6054 – 6058 (1986).
A. Coune, Eur. J. Cancer Clin. Oncol., 24(2), 117 – 121 (1988).
A. M. Feigin, Med. Hypotheses, 52(5), 383 – 388 (1999).
M. A. Shneider, in: Progress in the Study and Production of Antibiotics [in Russian], Trudy Vsesoyuzn. Nauch.-Issled. Instituta Antibiotikov (VNIIA), Izd. VNIIA, Moscow (1979), pp. 56 – 69.
M. A. Shneider, E. B. Shtil’bans, L. A. Rachkovskaya, and V. A. Poltorak, Antibiotiki, 28(5), 352 – 357 (1983).
M. A. Shneider, Mol. Genet. Mikrobiol. Virusol., No. 5, 41 – 46 (1984).
M. A. Shneider, N. K. Rudenko, V. M. Kavsan, and R. Sh. Bibilashvili, Mol. Biol. (Mosk.), 21(3), 837 – 846 (1987).
M. A. Shneider and N. P. Chizhov, Vopr. Virusol., 31(1), 18 – 31 (1986).
N. N. Klimko and A. V. Veselov, Klin. Mikrobiol. Antimikrob. Khimioter., 5(4), 342 – 353 (2003).
N. N. Klimko and A. S. Kolbin, Probl. Med. Mikol., 7(3), 3 – 11 (2005).
A. V. Veselov, Klin. Mikrobiol. Antimikrob. Khimioter., 9(1), 73 – 80 (2007).
J. C. Gallagher, C. MacDougall, E. S. Dodds-Ashley, and J. R. Perfect, Expert Rev. Anti-Infect. Ther., 2(2), 253 – 268 (2004).
G. Maschmeyer, A. Haas, and O. A. Cornely, Drugs, 67(10), 1567 – 1601 (2007).
G. Maschmeyer, T. Calandria, N. Singh, et al., Med. Mycol., 47(6), 571 – 583 (2009).
D. A. Stevens and K. Holmberg, Curr. Opin. Anti-Infect. Invest. Drugs, 1(3), 306 – 317 (1999).
D. Sanglard and F. C. Odds, Lancet Infect. Dis., 2(2), 73 – 85 (2002).
J. S. Hamdan and R. C. Hahn, Anti-Infect. Agents Med. Chem., 5(4), 403 – 412 (2006).
M. Slisz, B. Cybulska, J. Grzybowska, et al., J. Antibiot., 60(7), 436 – 446 (2007).
D. Sanglard, A. Coste, and S. Ferrari, FEMS Yeast Res., 9(7), 1029 – 1050 (2009).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 3, pp. 7 – 15, March, 2016.
Rights and permissions
About this article
Cite this article
Belakhov, V.V., Garabadzhiu, A.V., Kolodyaznaya, V.A. et al. Synthesis and Antifungal and Antiviral Activity of N-Benzyl Derivatives of the Tetraene Macrolide Antibiotic Lucensomycin. Pharm Chem J 50, 143–151 (2016). https://doi.org/10.1007/s11094-016-1412-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1412-3